ALLSCRIPTS HEALTHCARE SOLUTN - NOTE 1.250% 7/0 Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2014 to Q3 2020

Type / Class
Debt / NOTE 1.250% 7/0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ALLSCRIPTS HEALTHCARE SOLUTN - NOTE 1.250% 7/0 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2020 Q3 $0 $0 -$440,000 0
2020 Q2 $440,000 $440,000 -$285,672,798 100.0% 1
2020 Q1 $296,226,385 $286,093,798 +$13,480,339 96.24% 24
2019 Q4 $278,081,370 $278,102,506 -$36,509,401 99.25% 26
2019 Q3 $315,373,474 $314,534,317 -$13,145,193 99.36% 26
2019 Q2 $332,146,792 $334,126,809 +$23,440,693 100.09% 30
2019 Q1 $308,951,500 $303,978,392 -$22,993,429 97.95% 33
2018 Q4 $334,393,433 $323,280,322 -$18,620,062 96.55% 35
2018 Q3 $350,789,012 $370,321,394 +$13,676,917 105.5% 39
2018 Q2 $343,642,012 $348,136,566 +$25,102,025 101.16% 39
2018 Q1 $324,273,010 $325,901,593 -$19,095,913 100.37% 38
2017 Q4 $340,931,000 $365,188,579 +$24,739,467 107.02% 39
2017 Q3 $317,855,000 $337,693,156 -$4,841,526 106.2% 38
2017 Q2 $323,604,000 $330,520,500 +$18,678,081 101.56% 41
2017 Q1 $305,183,000 $307,047,500 -$12,963,458 100.38% 38
2016 Q4 $330,815,000 $311,950,875 -$19,846,937 94.0% 38
2016 Q3 $349,655,000 $359,033,300 -$931,152 102.52% 36
2016 Q2 $337,047,000 $338,394,000 -$4,451,015 100.37% 32
2016 Q1 $346,192,000 $353,139,718 +$11,362,131 102.03% 38
2015 Q4 $348,253,000 $375,457,000 +$18,203,923 108.14% 40
2015 Q3 $319,907,000 $318,200,249 +$14,682,687 99.16% 28
2015 Q2 $304,410,000 $313,303,830 +$34,220,900 102.65% 30
2015 Q1 $279,621,000 $274,702,000 -$7,652,773 98.3% 29
2014 Q4 $284,087,000 $267,768,000 -$532,067 98.58% 33
2014 Q3 $267,356,243 $274,031,261 +$263,668,261 101.2% 27
2014 Q2 $10,246,000 $10,833,000 +$10,833,000 105.73% 1